Imperagen raises £5 million for quantum physics and AI-driven enzyme engineering
Biotech startup Imperagen has raised a £5 million seed round led by PXN Ventures to advance its approach to enzyme engineering using quantum physics simulations, custom AI models, and automation. The funding aims to make the process faster, more efficient, and less costly than traditional methods.
Topics: AI in Biotechnology Biotech Enzyme Engineering Startups